These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

230 related articles for article (PubMed ID: 31140202)

  • 1. The effects of weight loss and metformin on cognition among breast cancer survivors: Evidence from the Reach for Health study.
    Hartman SJ; Nelson SH; Marinac CR; Natarajan L; Parker BA; Patterson RE
    Psychooncology; 2019 Aug; 28(8):1640-1646. PubMed ID: 31140202
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Recruitment strategies, design, and participant characteristics in a trial of weight-loss and metformin in breast cancer survivors.
    Patterson RE; Marinac CR; Natarajan L; Hartman SJ; Cadmus-Bertram L; Flatt SW; Li H; Parker B; Oratowski-Coleman J; Villaseñor A; Godbole S; Kerr J
    Contemp Clin Trials; 2016 Mar; 47():64-71. PubMed ID: 26706665
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of weight loss on bone health in overweight/obese postmenopausal breast cancer survivors.
    Toriola AT; Liu J; Ganz PA; Colditz GA; Yang L; Izadi S; Naughton MJ; Schwartz AL; Wolin KY
    Breast Cancer Res Treat; 2015 Aug; 152(3):637-43. PubMed ID: 26175059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Results of the Exercise and Nutrition to Enhance Recovery and Good Health for You (ENERGY) Trial: A Behavioral Weight Loss Intervention in Overweight or Obese Breast Cancer Survivors.
    Rock CL; Flatt SW; Byers TE; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Sedjo RL; Wyatt H
    J Clin Oncol; 2015 Oct; 33(28):3169-76. PubMed ID: 26282657
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Feasibility of a lifestyle intervention on body weight and serum biomarkers in breast cancer survivors with overweight and obesity.
    Campbell KL; Van Patten CL; Neil SE; Kirkham AA; Gotay CC; Gelmon KA; McKenzie DC
    J Acad Nutr Diet; 2012 Apr; 112(4):559-67. PubMed ID: 22709706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Metabolomic profiles of metformin in breast cancer survivors: a pooled analysis of plasmas from two randomized placebo-controlled trials.
    Bellerba F; Chatziioannou AC; Jasbi P; Robinot N; Keski-Rahkonen P; Trolat A; Vozar B; Hartman SJ; Scalbert A; Bonanni B; Johansson H; Sears DD; Gandini S
    J Transl Med; 2022 Dec; 20(1):629. PubMed ID: 36581893
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of metformin and lifestyle intervention on adipokines and hormones in breast cancer survivors: a pooled analysis from two randomized controlled trials.
    Johansson H; Bellerba F; Macis D; Bertelsen BE; Guerrieri-Gonzaga A; Aristarco V; Viste K; Mellgren G; Di Cola G; Costantino J; Scalbert A; Sears DD; Gandini S; DeCensi A; Bonanni B
    Breast Cancer Res Treat; 2024 May; 205(1):49-59. PubMed ID: 38279016
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of Metformin Treatment with Respect to Weight Reduction in Children and Adults with Obesity: A Systematic Review.
    Lentferink YE; Knibbe CAJ; van der Vorst MMJ
    Drugs; 2018 Dec; 78(18):1887-1901. PubMed ID: 30511324
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An epigenetic aging analysis of randomized metformin and weight loss interventions in overweight postmenopausal breast cancer survivors.
    Nwanaji-Enwerem JC; Chung FF; Van der Laan L; Novoloaca A; Cuenin C; Johansson H; Bonanni B; Hubbard AE; Smith MT; Hartman SJ; Cardenas A; Sears DD; Herceg Z
    Clin Epigenetics; 2021 Dec; 13(1):224. PubMed ID: 34920739
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of weight loss on physical function and symptoms in overweight or obese breast cancer survivors: results from POWER-remote.
    Sheng JY; Santa-Maria CA; Blackford AL; Lim D; Carpenter A; Smith KL; Cohen GI; Coughlin J; Appel LJ; Stearns V; Snyder C
    J Cancer Surviv; 2022 Jun; 16(3):542-551. PubMed ID: 34018096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. WISER Survivor Trial: Combined Effect of Exercise and Weight Loss Interventions on Adiponectin and Leptin Levels in Breast Cancer Survivors with Overweight or Obesity.
    Lin D; Sturgeon KM; Gordon BR; Brown JC; Sears DD; Sarwer DB; Schmitz KH
    Nutrients; 2023 Aug; 15(15):. PubMed ID: 37571390
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of a 12-week exercise-based intervention on weight management in overweight or obese breast cancer survivors: a randomized controlled trial.
    Zhao FY; Liu JE; Fang XM; Chen L; Liang JG; Liu Y; Li RL; Chen HR
    Support Care Cancer; 2024 Jan; 32(2):98. PubMed ID: 38200265
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Phase II study of metformin for reduction of obesity-associated breast cancer risk: a randomized controlled trial protocol.
    Martinez JA; Chalasani P; Thomson CA; Roe D; Altbach M; Galons JP; Stopeck A; Thompson PA; Villa-Guillen DE; Chow HH
    BMC Cancer; 2016 Jul; 16():500. PubMed ID: 27430256
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A cognitive behavioral therapy intervention to promote weight loss improves body composition and blood lipid profiles among overweight breast cancer survivors.
    Mefferd K; Nichols JF; Pakiz B; Rock CL
    Breast Cancer Res Treat; 2007 Aug; 104(2):145-52. PubMed ID: 17058023
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daughters and Mothers Against Breast Cancer (DAMES): main outcomes of a randomized controlled trial of weight loss in overweight mothers with breast cancer and their overweight daughters.
    Demark-Wahnefried W; Jones LW; Snyder DC; Sloane RJ; Kimmick GG; Hughes DC; Badr HJ; Miller PE; Burke LE; Lipkus IM
    Cancer; 2014 Aug; 120(16):2522-34. PubMed ID: 24804802
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of Behavioral Weight Loss and Metformin on IGFs in Cancer Survivors: A Randomized Trial.
    Yeh HC; Maruthur NM; Wang NY; Jerome GJ; Dalcin AT; Tseng E; White K; Miller ER; Juraschek SP; Mueller NT; Charleston J; Durkin N; Hassoon A; Lansey DG; Kanarek NF; Carducci MA; Appel LJ
    J Clin Endocrinol Metab; 2021 Sep; 106(10):e4179-e4191. PubMed ID: 33884414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized controlled trial of weight loss versus usual care on telomere length in women with breast cancer: the lifestyle, exercise, and nutrition (LEAN) study.
    Sanft T; Usiskin I; Harrigan M; Cartmel B; Lu L; Li FY; Zhou Y; Chagpar A; Ferrucci LM; Pusztai L; Irwin ML
    Breast Cancer Res Treat; 2018 Nov; 172(1):105-112. PubMed ID: 30062572
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlates of quality of life in overweight or obese breast cancer survivors at enrollment into a weight loss trial.
    Pakiz B; Ganz PA; Sedjo RL; Flatt SW; Demark-Wahnefried W; Liu J; Wolin KY; Rock CL
    Psychooncology; 2016 Feb; 25(2):142-9. PubMed ID: 25920528
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of a behavioral weight loss intervention on comorbidities in overweight and obese breast cancer survivors.
    Sedjo RL; Flatt SW; Byers T; Colditz GA; Demark-Wahnefried W; Ganz PA; Wolin KY; Elias A; Krontiras H; Liu J; Naughton M; Pakiz B; Parker BA; Wyatt H; Rock CL
    Support Care Cancer; 2016 Aug; 24(8):3285-93. PubMed ID: 26945570
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.